Results 61 to 70 of about 2,229 (127)

Bullous Wells’ syndrome successfully treated with omalizumab

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 5, Page 657-659, May 2026.
Giulia Ciccarese, William Andrew Rosato, Francesco Drago, Alexandre Raphael Meduri, Francesca Ambrogio, Aurora De Marco, Gerardo Cazzato, Caterina Foti   +7 more
wiley   +1 more source

A Case of Lichen Planus Pemphigoides Successfully Treated with a Combination of Cyclosporine A and Prednisolone

Case Reports in Dermatology, 2013
Lichen planus pemphigoides (LPP) is a rare clinical variant of bullous pemphigoid (BP). A 35-year-old female patient presented to our hospital complaining of pruritic violaceous-colored plaques or papules on the extremities. Tense vesicles were also seen
Ken Washio, Atsuko Nakamura, Shunpei Fukuda, Takashi Hashimoto, Tatsuya Horikawa   +4 more
doaj   +1 more source

Bullöses Wells‐Syndrom erfolgreich mit Omalizumab behandelt

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 5, Page 657-659, May 2026.
Giulia Ciccarese, William Andrew Rosato, Francesco Drago, Alexandre Raphael Meduri, Francesca Ambrogio, Aurora De Marco, Gerardo Cazzato, Caterina Foti   +7 more
wiley   +1 more source

Gliptin Accountability in Mucous Membrane Pemphigoid Induction in 24 Out of 313 Patients

Frontiers in Immunology, 2018
Mucous membrane pemphigoids (MMPs) and bullous pemphigoid (BP) are autoimmune bullous diseases that share physiopathological features: both can result from autoantibodies directed against BP180 or BP230 antigens.
Olivier Gaudin, Vannina Seta, Vannina Seta, Marina Alexandre, Gérôme Bohelay, Françoise Aucouturier, Sabine Mignot-Grootenboer, Saskia Ingen-Housz-Oro, Céline Bernardeschi, Pierre Schneider, Benoît Mellottee, Frédéric Caux, Catherine Prost-Squarcioni, Catherine Prost-Squarcioni, Catherine Prost-Squarcioni   +14 more
doaj   +1 more source

Redefining skin toxicity in the age of precision immunotherapy

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 5, Page 716-717, May 2026.
Florentia Dimitriou, Christian Posch
wiley   +1 more source

Home‐based collaborative management of bullous pemphigoid with delayed seropositive conversion of anti‐BP180‐NC16a antibody

Journal of General and Family Medicine
We report the case of an 82‐year‐old male with a history of multiple cerebral infarctions who developed bullous pemphigoid while receiving home‐based care.
Hiromitsu Yamashita, Takayuki Ando, Hirohisa Fujikawa, Masayoshi Shiota   +3 more
doaj   +1 more source

The flavonoid luteolin inhibits Fcγ-dependent respiratory burst in granulocytes, but not skin blistering in a new model of pemphigoid in adult mice.

PLoS ONE, 2012
Bullous pemphigoid is an autoimmune blistering skin disease associated with autoantibodies against the dermal-epidermal junction. Passive transfer of antibodies against BP180/collagen (C) XVII, a major hemidesmosomal pemphigoid antigen, into neonatal ...
Eva Oswald, Alina Sesarman, Claus-Werner Franzke, Ute Wölfle, Leena Bruckner-Tuderman, Thilo Jakob, Stefan F Martin, Cassian Sitaru   +7 more
doaj   +1 more source

A rare case of keloid combined with bullous pemphigoid

Dermatology Reports
Keloids and bullous pemphigoid (BP) are two clinically and pathophysiologically distinct dermatologic disorders – the former involves abnormal scar formation due to excess collagen deposition, while the latter is an autoimmune blistering disease.
Ying Zhang, Yiyi Gong, Xiangguang Shi, Huyan Chen, Yining Wei, Wenyu Wu, Mengguo Liu   +6 more
doaj   +1 more source

The expression levels of IL-4 and IL-13 in the serum and blister fluid of patients with bullous pemphigoid

Pifu-xingbing zhenliaoxue zazhi
Objective To investigate the expression levels of type 2 inflammatory cytokines, IL-4 and IL-13, in the serum and blister fluid of patients with bullous pemphigoid (BP).
Yao ZHOU, Lijun TENG, Guomin LI, Jie XU, Jinjin ZHENG, Hao FANG, Ruzeng XUE   +6 more
doaj   +1 more source

Peristomal bullous pemphigoid: expanding the spectrum of localized presentations. [PDF]

An Bras Dermatol
Ramírez-Bravo F, Contreras CA, Marcet GH, Martínez IW, Urrutia MJ, Castro A.   +5 more
europepmc   +1 more source